使用dinoprostone慢释放性阴道插入物用于宫成熟的终期怀孕与oligohydramnios
To Nhu Thi Ngo Nguyen1, Anh Dinh Bao Vuong1, Phuc Nhon Nguyen1,2
1Department of High-Risk Pregnancy, Tu Du Hospital, Ho Chi Minh City, Vietnam.
The journal of obstetrics and gynaecology research
|May 27, 2023
概括
迪诺普罗斯阴道插件显示,在有氧水症的孕妇中,子宫成熟的成功率为57.5%. 像BMI和催产素这样的因素影响了成功的成熟,帮助产科医生预测结果.
科学领域:
- 产科和妇科 产科和妇科
- 生殖医学 生殖医学
- 孕产妇和胎儿医学 孕产妇和胎儿医学
背景情况:
- 长期怀孕中的橄水症对产生的诱导提出了挑战.
- 宫成熟对于成功的阴道分娩至关重要.
- 控制释放的阴道插件是宫成熟的常见方法.
研究的目的:
- 为了评估宫成熟的成功率,使用dinooprostone控制释放阴道插件.
- 为了确定与成功的宫成熟相关的因素,在终期怀孕与oligohydramnios.
主要方法:
- 一项涉及200名孕妇的横截面研究,妊娠年龄≥37周,有氧水.
- 进行了迪诺普罗斯子宫成熟 (DCR) 的治疗.
- 成功的宫成熟 (SCR) 被定义为在24小时后Bishop分数≥7.
主要成果:
- DCR的整体成功率为57.5%,剖腹产分娩率为46.5%.
- 较高的体重指数 (BMI ≥25 kg/m2) 和催产素输注与SCR显著相关 (aOR分别为3.67和4.68).
- 毕晓普分数≥3与宫成熟时间较短相关 (HR 1.38).
结论:
- 迪诺普罗斯阴道插件是一种可行的选择,用于宫成熟,以期怀孕与oligohydramnios.
- 产科医生可以通过评估诸如BMI和催产素需求等因素来预测成功的成熟.
- 需要进一步的研究来证实这些发现,并优化临床实践.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
225
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
225
In Vitro Fertilization
338
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
338
Drugs for Treatment of Constipation-Predominant IBS
236
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
236
Mitral Valve Prolapse III: Nursing Management
20
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
20
Ovarian Cycle
1.4K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.4K
Parenteral Anesthetics: Overview
163
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
163


